The acquisition will have a $600 million upfront payment and up to another $1.1 billion pending regulatory and commercial milestones, according to an Aug. 20 J&J news release.
V-Wave is a privately held company that targets heart failure with reduced ejection fraction, and its Ventura Interatrial Shunt addressed an unmet need for about 800,000 patients, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
